RETRACTED ARTICLE: Hypoxia impairs decitabine-induced expression of HLA-DR in acute myeloid leukaemia cell lines
Abstract Background Hypomethylating agents (HMA), such as azacytidine (AZA) and decitabine (DAC), are epigenetic therapies used to treat some patients with acute myeloid leukaemia (AML) and myelodysplastic syndrome. HMAs act in a replication-dependent manner to remove DNA methylation from the genome...
Kaydedildi:
| Asıl Yazarlar: | , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BMC
2025-01-01
|
| Seri Bilgileri: | Clinical Epigenetics |
| Konular: | |
| Online Erişim: | https://doi.org/10.1186/s13148-025-01812-4 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|